Cargando…
Mass Spectrometry Approaches for Identification and Quantitation of Therapeutic Monoclonal Antibodies in the Clinical Laboratory
Therapeutic monoclonal antibodies (MAbs) are an important class of drugs used to treat diseases ranging from autoimmune disorders to B cell lymphomas to other rare conditions thought to be untreatable in the past. Many advances have been made in the characterization of immunoglobulins as a result of...
Autores principales: | Ladwig, Paula M., Barnidge, David R., Willrich, Maria A. V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424237/ https://www.ncbi.nlm.nih.gov/pubmed/28274937 http://dx.doi.org/10.1128/CVI.00545-16 |
Ejemplares similares
-
Ravulizumab: Characterization and quantitation of a new C5 inhibitor using isotype specific affinity purification and high-resolution mass spectrometry
por: Ladwig, Paula M., et al.
Publicado: (2021) -
Comparing cellular proteomes by mass spectrometry
por: Fröhlich, Florian, et al.
Publicado: (2009) -
Clinical application of SARS-CoV-2 antibody detection and monoclonal antibody therapies against COVID-19
por: Sun, Jin, et al.
Publicado: (2023) -
The state of the art: immune-mediated mechanisms of monoclonal antibodies in cancer therapy
por: Griggs, J, et al.
Publicado: (2009) -
Induction Therapy for Kidney Transplant Recipients: Do We Still Need Anti‐IL2 Receptor Monoclonal Antibodies?
por: Hellemans, R., et al.
Publicado: (2016)